CoQ10 400 mg

CoQ10 400 mg

NOW4.8 (2,205 ratings)
Format:Softgel Quantity: 60 Softgel(s) · 60 servings
Goals

Product analysis

54 out of 100

CoQ10 400 mg may support some blood-pressure and blood-fat measures, although results vary between people and preparations. The unspecified CoQ10 form makes it hard to judge whether it matches the preparations behind those findings.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality26

The CoQ10 form is not identified, leaving its quality uncertain. Naming the vitamin E form does not establish the quality of the combination.

Ingredient Transparency70

Amounts are listed for each ingredient, but CoQ10 and lecithin lack specific forms. Only vitamin E has its form identified, limiting detailed comparisons.

Value For Money40

The CoQ10 serving cost is less competitive. Value for vitamin E and lecithin remains uncertain.

Customer Satisfaction88

Customer satisfaction is high across a substantial review base. Ratings do not establish changes in heart health or energy.

Product Focus71

CoQ10 has limited support for changes in selected cardiovascular and inflammation markers. A larger serving does not establish extra energy, weight loss or slower aging.

Format
Softgel
Container
60 Softgel(s)
Per serving
$0.65
Customer rating
4.8 · 2,205 ratings
Report analysis

Goals

Cardiovascular Support
Impact
Highest effect
B Ingredient FitC PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mgVitamin E · 20 mg

CoQ10 has limited support for blood-pressure, lipid and vessel-function markers in adults with abnormal blood lipids. The findings concern measured markers and do not establish cardiovascular-event prevention. Higher amounts do not establish proportionately larger benefits.

How this product is rated for Cardiovascular Support

Ingredient fit79

Skin-related ingredients appear within a broader formula with other intended uses. The counted amounts meet the comparison range, without establishing that larger intakes improve cardiovascular further.
Goal fit
Skin-related ingredients appear within a broader formula with other intended uses.
Dose adequacy
The counted amounts meet the comparison range, without establishing that larger intakes improve cardiovascular further.

Pathways60

Endothelial nitric-oxide function is the strongest assigned cardiovascular role; the result does not establish the complete product's clinical effect. The recorded reach is concentrated in one cardiovascular role.
Depth
Endothelial nitric-oxide function is the strongest assigned cardiovascular role; the result does not establish the complete product's clinical effect.
Breadth
The recorded reach is concentrated in one cardiovascular role.

Evidence88

Coenzyme Q-10 leads the evidence finding, subject to its specific clinical and population limitations. The counted ingredients match the saved preparation requirements, without confirming a trial of this complete formula.
Evidence strength
Coenzyme Q-10 leads the evidence finding, subject to its specific clinical and population limitations.
Studied preparation
The counted ingredients match the saved preparation requirements, without confirming a trial of this complete formula.

Formulation logic100

The evaluated ingredients have no missing required partner or configured conflict. All counted amounts pass the minimum comparison.
Partner coverage
No required partner is missing from the counted ingredients; this does not establish an additional combination benefit.
Conflicts
No configured conflict was identified among the evaluated ingredients.
Effective doses
All counted ingredients pass the minimum amount comparison; passing it does not prove a clinical cardiovascular benefit.
Study evidence
Vitamin E Mixed 79 studies
Heart Health
Impact
High effect
C- Ingredient FitD PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 may support blood-vessel function and produce modest blood-pressure or lipid changes in selected adults, but findings are mixed. This 400 mg serving receives a reduced amount comparison in the saved result; that reduction is a comparison policy, not evidence that this amount works less well. The supplied evidence does not establish cardiovascular-event prevention or greater benefit from the larger serving.

How this product is rated for Heart Health

Ingredient fit59

CoQ10 provides the main relevant connection. The amount findings remain partial across the counted ingredients.
Goal fit
CoQ10 provides the main heart-related connection within a formula that also contains ingredients directed toward other goals.
Dose adequacy
The counted ingredients receive partial overall amount recognition; the comparison does not establish a proven effective dose or personal suitability.

Pathways47

The saved findings concentrate on blood-vessel function. Other pathways do not reach the breadth threshold.
Depth
The strongest saved contribution is in blood-vessel function.
Breadth
Only blood-vessel function reaches the saved breadth threshold; the findings remain concentrated in that area.

Evidence98

CoQ10 leads the saved evidence comparison, but its blood-pressure and lipid findings are mixed and limited to selected populations. The saved preparation finding recognizes the counted preparations.
Evidence strength
CoQ10 leads the saved evidence comparison, but its blood-pressure and lipid findings are mixed and limited to selected populations.
Studied preparation
The counted ingredients qualify as studied preparations in the saved findings; this does not establish product-specific trial results or superior delivery.

Formulation logic100

Partner requirements are satisfied and the counted ingredients meet the saved minimum amount comparison. No configured ingredient conflict was matched in the supplied facts.
Partner coverage
The counted ingredients have no unmet partner requirement in the saved findings; this does not imply extra benefit from combining them.
Conflicts
No configured ingredient conflict was matched in the supplied facts.
Effective doses
All counted ingredients meet the saved minimum amount comparison; this threshold is not a clinically proven effective dose.
Study evidence
Metabolism Support
Impact
High effect
B- Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

Coenzyme Q-10 helps the cellular machinery that transfers energy, but this normal role does not establish that supplementation increases whole-body calorie expenditure. The supplied studies concern metabolic markers rather than a general increase in metabolic rate. Its known amount receives a saved contribution, without demonstrating thermogenesis or sustained weight loss.

How this product is rated for Metabolism Support

Ingredient fit72

Coenzyme Q-10 supplies the saved ingredient contribution, but its normal cellular role does not establish increased whole-body energy expenditure.
Goal fit
Other actives broaden the formula beyond this goal, reducing its focus.
Dose adequacy
The counted amounts reach the saved comparison range; that range is not a proven dose for increasing calorie expenditure.

Pathways54

The strongest saved functional coverage concerns mitochondrial energy and fat oxidation. That mechanism does not by itself establish greater whole-body energy expenditure.
Depth
The strongest saved contribution concerns mitochondrial energy and fat oxidation, with partial functional coverage.
Breadth
The saved findings cover mitochondrial energy and fat oxidation; other functions remain less supported.

Evidence75

Coenzyme Q-10 is the strongest saved evidence contributor. The supplied scientific context does not establish a routine increase in calorie expenditure.
Evidence strength
Coenzyme Q-10 supplies the strongest saved evidence contribution; this does not override limitations in the direct energy-expenditure findings.
Studied preparation
The counted amounts match preparations accepted in the saved comparison.

Formulation logic100

The counted ingredients can contribute independently and no configured conflict is found. Their known amounts pass the saved minimum.
Partner coverage
The counted ingredients can contribute independently or have the required partner.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The counted amounts pass the saved minimum, which does not establish a proven increase in energy expenditure.
Study evidence
Inflammation
Impact
High effect
B- Ingredient FitD+ PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mgVitamin E · 20 mg

CoQ10 is relevant to oxidative and mitochondrial stress, with limited evidence for changes in inflammatory markers. The studied ubiquinone regimen used 300 mg daily for 12 weeks in people with coronary artery disease taking statins; some markers changed while others did not. This serving supplies 400 mg, so its amount does not establish the same regimen or routine clinical benefit.

How this product is rated for Inflammation

Ingredient fit72

CoQ10 is the main relevant ingredient. Other actives reduce the formula’s focus on this goal.
Goal fit
CoQ10 provides the main relevant ingredient focus; other actives make the formula less focused on this goal.
Dose adequacy
The 400 mg serving differs from the reviewed 300 mg daily regimen; the amount alone does not establish equivalent benefit.

Pathways52

The contribution is concentrated in oxidative and mitochondrial stress, rather than broad coverage of the assessed inflammatory routes.
Depth
CoQ10 supplies the main contribution in oxidative and mitochondrial stress.
Breadth
Only oxidative and mitochondrial stress reaches the coverage threshold; the other assessed routes add no coverage.

Evidence93

CoQ10 supplies the main evidence connection, with a reviewed ubiquinone preparation and context-limited biomarker findings.
Evidence strength
CoQ10 leads the evidence finding, based on limited biomarker results in statin-treated coronary artery disease.
Studied preparation
The supplied policy treats unspecified CoQ10 as ordinary ubiquinone, the reviewed preparation.

Formulation logic100

CoQ10 can contribute independently, with no configured ingredient conflict identified.
Partner coverage
CoQ10 can contribute without a required companion ingredient.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
CoQ10 meets the amount threshold used for inclusion; this is not a proven effective clinical dose.
Study evidence
Vitamin E Supportive 20 studies
Longevity
Impact
High effect
B- Ingredient FitC+ PathwaysC EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

Coenzyme Q-10 supports mitochondrial energy processes and vitamin E has antioxidant roles. The supplied visible-skin evidence concerns the specific water-soluble Q10Vital preparation, not generic CoQ10 or simply a larger amount. This formula does not establish the same wrinkle or smoothness effect, and antioxidant activity alone does not establish slower aging. The 400 mg CoQ10 serving does not resolve that preparation limitation.

How this product is rated for Longevity

Ingredient fit75

CoQ10 and vitamin E contribute, with another active and broad goal links reducing focus.
Goal fit
CoQ10 and vitamin E contribute, with another active and broad goal links reducing focus.
Dose adequacy
Amounts receive partial recognition overall; generic CoQ10 does not establish preparation equivalence.

Pathways65

Antioxidant defense is the strongest represented area in the saved findings. Mitochondrial energy production also reaches the coverage threshold.
Depth
Antioxidant defense is the strongest mapped area; the mapping does not establish slower aging or longer life.
Breadth
Antioxidant defense and mitochondrial energy production reach the saved coverage threshold; other areas do not.

Evidence60

Vitamin E leads the saved evidence finding. CoQ10 lacks the recognized studied preparation.
Evidence strength
Vitamin E leads the saved evidence finding; its role does not establish universal anti-aging benefit.
Studied preparation
CoQ10 lacks the recognized studied preparation.

Formulation logic100

No unmet partner requirement or configured conflict was found. All credited ingredients clear the amount threshold used for inclusion.
Partner coverage
Each credited ingredient works independently or has its required partner.
Conflicts
No configured conflict was matched among the evaluated combinations.
Effective doses
All credited ingredients clear the inclusion threshold; this does not prove an effective anti-aging dose.
Study evidence
Vitamin E Supportive 19 studies
Energy
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 takes part in mitochondrial energy production and has limited preparation-specific fatigue evidence. The 400 mg declaration is not matched to a studied redox form in the saved findings, so the amount alone does not establish a comparable fatigue benefit.

How this product is rated for Energy

Ingredient fit72

1 assessed ingredients relate to energy alongside 2 other active ingredients, giving the formula a broader focus. The assessed amount meets the saved dose benchmark.
Goal fit
1 assessed ingredients relate to energy alongside 2 other active ingredients, giving the formula a broader focus.
Dose adequacy
The assessed amount meets the saved dose benchmark.

Pathways17

The strongest saved connection is to mitochondrial energy production, with limited coverage. None of the three target areas reaches the saved threshold for substantial coverage.
Depth
The strongest saved connection is to mitochondrial energy production, with limited coverage.
Breadth
None of the three target areas reaches the saved threshold for substantial coverage.

Evidence27

Coenzyme Q-10 provides the strongest saved evidence among ingredients meeting the amount benchmark. That finding does not establish extra energy from the whole formula. Preparation matching is incomplete for Coenzyme Q-10, limiting direct transfer of results from specific preparations.
Evidence strength
Coenzyme Q-10 provides the strongest saved evidence among ingredients meeting the amount benchmark. That finding does not establish extra energy from the whole formula.
Studied preparation
Preparation matching is incomplete for Coenzyme Q-10, limiting direct transfer of results from specific preparations.

Formulation logic100

The assessed ingredients can act independently or have their required partner present. No configured ingredient conflicts were identified in the saved findings. 1 of 1 assessed ingredients meet the saved minimum amount benchmark.
Partner coverage
The assessed ingredients can act independently or have their required partner present.
Conflicts
No configured ingredient conflicts were identified in the saved findings.
Effective doses
1 of 1 assessed ingredients meet the saved minimum amount benchmark.
Study evidence

Ingredients

IngredientAmount per servingScore
Calories
5 Calorie(s)
Total Fat
0.5 Gram(s)
Vitamin E (D-Alpha-Tocopherol)
20 mg
Coenzyme Q10
400 mg 42
Sunflower Lecithin
35 mg
Gluten Free Adults 18–50 Kosher Dairy Free
Report overview
Coenzyme Q-10 · 400 mg OverallScore42
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyD- Value
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
    Loffredo L; Perri L; Di Castelnuovo A; Iacoviello L; De Gaetano G; Violi F · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2016
    Meta-analysis16 studies pooledCardiovascular Support forVitamin E
  7. Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
    Chen B; Li Y; Li Z; Hu X; Zhen H; Chen H; Nie C; Hou Y; Zhu S; Xiao L; Li T · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2025
    Randomized trial90 participantsCardiovascular Support forVitamin E
  8. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
    Lonn E; Bosch J; Yusuf S; Sheridan P; Pogue J; Arnold JM; Ross C; Arnold A; Sleight P; Probstfield J; Dagenais GR; HOPE and HOPE-TOO Trial Investigators · JAMA · 2005
    Randomized trial9,541 participantsCardiovascular Support forVitamin E
  9. Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
    Liu Z; He Z; Xing Y · Journal of nutritional science · 2026
    Cohort study34,955 participantsCardiovascular Support forVitamin E
  10. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
    Chin SF; Ibahim J; Makpol S; Abdul Hamid NA; Abdul Latiff A; Zakaria Z; Mazlan M; Mohd Yusof YA; Abdul Karim A; Wan Ngah WZ · Nutrition & metabolism · 2011
    Randomized trial62 participantsCardiovascular Support forVitamin E
  11. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  12. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  13. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  14. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  15. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  16. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  17. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  18. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  19. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  20. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10